Wells Fargo & Company Tekla Life Sciences Investors Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Wells Fargo & Company holds 1,147 shares of HQL stock, worth $19,097. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,147

Previous 193 494.3%

Holding current value

$19,097

Previous $2,000 750.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$12.76 - $15.51 $12,173 - $14,796	954 Added 494.3%	1,147 $17,000
Q2 2025 Aug 14, 2025	SELL	$10.87 - $13.02 $46,817 - $56,077	-4,307 Reduced 95.71%	193 $2,000
Q1 2025 May 13, 2025	SELL	$12.69 - $14.36 $10,951 - $12,392	-863 Reduced 16.09%	4,500 $57,000
Q4 2024 Feb 12, 2025	SELL	$13.12 - $15.25 $99,777 - $115,976	-7,605 Reduced 58.64%	5,363 $70,000
Q3 2024 Nov 13, 2024	BUY	$14.26 - $15.78 $150,770 - $166,841	10,573 Added 441.46%	12,968 $195,000

Q2 2024 Aug 13, 2024	BUY	$12.79 - $14.27 $17,662 - $19,706	1,381 Added 136.19%	2,395 $33,000
Q1 2024 May 10, 2024	BUY	$13.38 - $14.33 $2,060 - $2,206	154 Added 17.91%	1,014 $13,000
Q4 2023 Feb 09, 2024	SELL	$11.35 - $13.6 $100,731 - $120,700	-8,875 Reduced 91.17%	860 $11,000
Q3 2023 Nov 13, 2023	SELL	$12.38 - $13.69 $1.18 Million - $1.31 Million	-95,703 Reduced 90.77%	9,735 $121,000
Q2 2023 Aug 15, 2023	SELL	$13.13 - $14.17 $257,886 - $278,312	-19,641 Reduced 15.7%	105,438 $1.43 Million
Q1 2023 May 12, 2023	SELL	$13.37 - $14.94 $2.12 Million - $2.37 Million	-158,468 Reduced 55.89%	125,079 $1.74 Million
Q4 2022 Feb 13, 2023	SELL	$13.55 - $15.23 $744,342 - $836,629	-54,933 Reduced 16.23%	283,547 $4.03 Million
Q3 2022 Nov 14, 2022	BUY	$13.39 - $16.31 $605,147 - $737,114	45,194 Added 15.41%	338,480 $4.62 Million
Q2 2022 Aug 12, 2022	BUY	$13.11 - $17.02 $160,230 - $208,018	12,222 Added 4.35%	293,286 $4.17 Million
Q1 2022 May 16, 2022	SELL	$15.35 - $19.29 $327,001 - $410,934	-21,303 Reduced 7.05%	281,064 $4.65 Million
Q4 2021 Feb 14, 2022	SELL	$18.5 - $21.59 $763,587 - $891,127	-41,275 Reduced 12.01%	302,367 $5.82 Million
Q3 2021 Nov 15, 2021	BUY	$20.27 - $22.67 $337,819 - $377,818	16,666 Added 5.1%	343,642 $7.15 Million
Q2 2021 Aug 16, 2021	SELL	$19.14 - $21.44 $1.49 Million - $1.67 Million	-77,818 Reduced 19.22%	326,976 $7.01 Million
Q1 2021 May 13, 2021	SELL	$19.31 - $22.07 $669,574 - $765,277	-34,675 Reduced 7.89%	404,794 $7.98 Million
Q4 2020 Feb 09, 2021	BUY	$16.8 - $20.21 $2.58 Million - $3.11 Million	153,643 Added 53.75%	439,469 $8.68 Million
Q3 2020 Nov 05, 2020	BUY	$16.71 - $19.06 $679,411 - $774,960	40,659 Added 16.58%	285,826 $5.03 Million
Q2 2020 Aug 13, 2020	SELL	$14.22 - $18.38 $142,043 - $183,597	-9,989 Reduced 3.91%	245,167 $4.4 Million
Q1 2020 May 14, 2020	BUY	$12.22 - $17.99 $3.12 Million - $4.59 Million	255,156 New	255,156 $3.82 Million

Others Institutions Holding HQL

# of Institutions

Shares Held

9.43M

Call Options Held

Put Options Held

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Tekla Life Sciences Investors Transaction History